Search
for
Sort by
Research 241–270 of 1000+
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- A falling out following minoxidil: Telogen effluvium
- A study on dermatoses of pregnancy
- Focal and Generalized Alopecia
- Erythema multiforme in a Central American tapir (Tapirus bairdii) calf, clinical case report
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Cutaneous reactions to recombinant cytokine therapy
- Effect of Hataedock Treatment on Epidermal Structure Maintenance through Intervention in the Endocannabinoid System
- Secondary Cicatricial Scalp Alopecia Caused by Brunsting-Perry Pemphigoid: A Case Report
- Skin Diseases in Horses
- The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases
- Atlas of Geriatric Dermatology
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- JAK inhibitors in dermatology: The promise of a new drug class
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- Acne and Hidden Iodides
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Cutaneous Drug Reaction Case Reports
- Physiologic changes and dermatoses of pregnancy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Medications
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Stress-related skin disorders
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Skin disease in pregnancy
- The Pathological Changes and Polymorphonuclear and Mast Cell Responses in the Skin of Specific Pathogen‐free Lambs Following Primary and Secondary Challenge with Orf Virus
- Dermatological drugs, topical agents, and cosmetics
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib